Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma - The Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF

European Journal of Gynaecological Oncology

Volumn 27, Issue 2, 2006, Pages 129-134

  Saito, M ^a   Watanabe, J ^a,b   Fujisawa, T ^a   Kamata, Y ^a   Nishimura, Y ^a   Arai, T ^a   Miyamoto, T ^a   Obokata, A ^a   Kuramoto, H ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiopoietins; Endometrial adenocarcinoma; Tie2

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL DIAMETER; CARCINOGENESIS; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; PROTEIN EXPRESSION; TUMOR BLOOD FLOW; TUMOR CELL; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, TIE-2; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645971903     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gale N.W., Yancopoulos G.D.: "Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development". Genes Dev., 1999, 13, 1055.
2. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V. et al.: "Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning". Cell, 1996, 87, 1161.
3. Sato A., Iwama A., Takakura N., Nishio H., Yancopoulos G.D., Suda T.: "Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells". Int. Immunol., 1998, 10, 1217.
4. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S. et al.: "Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis". Cell, 1996,87,1171.
5. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Old-mixon E.H. et al.: "Increased vascularization in mice overexpressing angiopoietin-1". Science, 1998, 282, 468.
6. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C. et al.: "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis". Science, 1997, 277, 55.
7. Asahara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M. et al.: "Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization". Circ. Res., 1998, 83, 233.
8. Abulafia O., Triest W.E., Sherer D.M.: "Angiogenesis in malignancies of the female genital tract". Gynecol. Oncol., 1999, 72, 220.
9. Holland C.M., Day K., Evans A., Smith S.K.: "Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer". Br. J. Cancer, 2003, 89, 891.
10. FIGO: "FIGO news". Int. J. Gynecol. Obstet., 2003, 28, 189.
11. Fujisawa T., Watanabe J., Akaboshi M., Ohno E., Kuramoto H.: "Immunohistochemical study on VEGF expression in endometrial carcinoma - comparison with p53 expression, angiogenesis, and tumor histologic grade". J. Cancer Res. Clin. Oncol., 2001, 127, 668.
12. Hewett P., Nijjar S., Shams M., Morgan S., Gupta J., Ahmed A.: "Down-regulation of angiopoietin-1 expression in menorrhagia". Am. J. Pathol., 2002, 160, 773.
13. Hirchenhain J., Huse I., Hess A., Bielfeld P., Bruyne F.D., Krüssel J.S.: "Differential expression of angiopoietins 1 and 2 and their receptor Tie-2 in human endometrium". Mol. Hum. Reprod., 2003, 9, 663.
14. Akaboshi M., Watanabe J., Fujisawa T., Hattori M., Ohno E., Kuramoto H.: "Immunohistochemical expression of cdk2 and Ki-67 in human endometrial carcinoma". J. Jpn. Soc. Clin. Cytol., 2001, 40, 121.
15. Mandriota S.J., Pepper M.S.: "Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia". Circ. Res., 1998, 83, 852.
16. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., Honda Y.: "Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells". J. Biol. Chem., 1999, 274, 15732.
17. Mandriota S.J., Pyke C., Di Sanza C., Quinodoz P., Pittet B., Pepper M.S.: "Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia". Am. J. Pathol., 2000, 156, 2077.
18. Abdulmalek K., Ashur F., Ezer N., Ye F., Magder S., Hussain S.N.: "Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats". Am. J. Physiol. Lung Cell. Mol. Physiol., 2001, 281, L582.
19. Yamakawa M., Liu L.X., Date T., Belanger A.J., Vincent K.A., Akita G.Y. et al.: "Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors". Circ. Res., 2003, 93, 664.
20. Etoh T., Inoue H., Tanaka S., Barnard G.F., Kitano S., Mori M.: "Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases". Cancer Res., 2001, 61, 2145.
21. Tanaka K., Sonoo H., Kurebayashi J., Nomura T., Ohkubo S., Yamamoto Y., Yamamoto S.: "Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma". Clin. Cancer Res., 2002, 8, 1125.
22. Holash J., Wiegand S.J., Yancopoulos G.D.: "New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF". Oncogene, 1999, 18, 5356.
23. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J.: "Vascular-specific growth factors and blood vessel formation". Nature, 2000, 407, 242.
24. Mitsuhashi N., Shimizu H., Ohtsuka M., Wakabayashi Y., Ito H., Kimura F. et al: "Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma". Hepatology, 2003, 37, 1105.
25. Tanaka F., Ishikawa S., Yanagihara K., Miyahara R., Kawano Y., Li M. et al.: "Expression of angiopoietins and its clinical significance in non-small cell lung cancer". Cancer Res., 2002, 62, 7124.